{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:50:55Z","timestamp":1783432255672,"version":"3.54.6"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Although some studies have shown that tranexamic acid is beneficial to patients with intracranial haemorrhage, the efficacy and safety of tranexamic acid for intracranial haemorrhage remain controversial.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Method<\/jats:title>\n<jats:p>The PubMed, EMBASE, and Cochrane Library databases were systematically searched. The review followed PRISMA guidelines. Data were analyzed using the random-effects model.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-five randomized controlled trials were included. Tranexamic acid significantly inhibited hematoma growth in intracranial hemorrhage (ICH) and traumatic brain injury (TBI) patients. (ICH: mean difference -1.76, 95%CI -2.78 to -0.79, I<jats:sup>2<\/jats:sup> = 0%, P &lt; .001; TBI: MD -4.82, 95%CI -8.06 to -1.58, I<jats:sup>2<\/jats:sup> = 0%, P = .004). For subarachnoid hemorrhage (SAH) patients, it significantly decreased the risk of hydrocephalus (OR 1.23, 95%CI 1.01 to 1.50, I<jats:sup>2<\/jats:sup> = 0%, P = .04) and rebleeding (OR, 0.52, 95%CI 0.35 to 0.79, I<jats:sup>2<\/jats:sup> = 56% P = .002). There was no significance in modified Rankin Scale, Glasgow Outcome Scale 3\u20135, mortality, deep vein thrombosis, pulmonary embolism, or ischemic stroke\/transient ischemic.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Tranexamic acid can significantly reduce the risk of intracranial haemorrhage growth in patients with ICH and TBI. Tranexamic acid can reduce the incidence of complications (hydrocephalus, rebleeding) in patients with SAH, which can indirectly improve the quality of life of patients with intracranial haemorrhage.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0282726","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:10:33Z","timestamp":1680286233000},"page":"e0282726","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis"],"prefix":"10.1371","volume":"18","author":[{"given":"Yu","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Goldbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lampis","family":"Stavrinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Stavrinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4428-4450","authenticated-orcid":true,"given":"Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"10","key":"pone.0282726.ref001","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","article-title":"Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial","volume":"48","author":"AY Fouda","year":"2017","journal-title":"Stroke"},{"issue":"10","key":"pone.0282726.ref002","doi-asserted-by":"crossref","first-page":"105136","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105136","article-title":"Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.","volume":"29","author":"C Jiang","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"pone.0282726.ref003","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.","volume":"19","author":"A Meretoja","year":"2020","journal-title":"Lancet Neurol"},{"key":"pone.0282726.ref004","doi-asserted-by":"crossref","first-page":"677744","DOI":"10.3389\/fnins.2021.677744","article-title":"Clinical Strategies Against Early Hematoma Expansion Following Intracerebral Hemorrhage.","volume":"15","author":"K Tanaka","year":"2021","journal-title":"Front Neurosci."},{"issue":"2","key":"pone.0282726.ref005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/svn-2021-001070","article-title":"Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial","volume":"7","author":"N Yassi","year":"2022","journal-title":"Stroke and vascular neurology"},{"issue":"5","key":"pone.0282726.ref006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.","volume":"72","author":"PL McCormack","year":"2012","journal-title":"Drugs"},{"issue":"10135","key":"pone.0282726.ref007","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.","volume":"391","author":"N Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"pone.0282726.ref008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13054-019-2492-8","article-title":"Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.","volume":"23","author":"JB Kuramatsu","year":"2019","journal-title":"Crit Care."},{"key":"pone.0282726.ref009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anae.12910","article-title":"The current place of tranexamic acid in the management of bleeding.","volume":"701","author":"BJ Hunt","year":"2015","journal-title":"Anaesthesia"},{"issue":"10","key":"pone.0282726.ref010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11910-017-0783-5","article-title":"Management of Spontaneous Intracerebral Hemorrhage.","volume":"17","author":"R Veltkamp","year":"2017","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"5","key":"pone.0282726.ref011","doi-asserted-by":"crossref","first-page":"e019130","DOI":"10.1161\/JAHA.120.019130","article-title":"Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.","volume":"10","author":"ZK Law","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"pone.0282726.ref012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jamaneurol.2022.0217","article-title":"Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial","volume":"79","author":"S Pszczolkowski","year":"2022","journal-title":"JAMA Neurol"},{"issue":"4","key":"pone.0282726.ref013","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"O Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"key":"pone.0282726.ref014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clineuro.2016.11.022","article-title":"Is clipping better than coiling in the treatment of patients with oculomotor nerve palsies induced by posterior communicating artery aneurysms? A systematic review and meta-analysis","volume":"153","author":"F Zheng","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"pone.0282726.ref015","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"M Cumpston","year":"2019","journal-title":"The Cochrane database of systematic reviews."},{"issue":"Spec Issue","key":"pone.0282726.ref016","first-page":"62","article-title":"Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages.","volume":"22","author":"A Arumugam","year":"2015","journal-title":"Malays J Med Sci"},{"issue":"2","key":"pone.0282726.ref017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/svn-2021-000942","article-title":"Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.","volume":"6","author":"J Liu","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"6","key":"pone.0282726.ref018","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","article-title":"Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461).","volume":"23","author":"N Sprigg","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"pone.0282726.ref019","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410030607","article-title":"Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial","volume":"3","author":"B. Chandra","year":"1978","journal-title":"Ann Neurol"},{"issue":"2","key":"pone.0282726.ref020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","article-title":"Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.","volume":"8","author":"H Fodstad","year":"1981","journal-title":"Neurosurgery"},{"issue":"546","key":"pone.0282726.ref021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/pgmj.47.546.199","article-title":"Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms","volume":"47","author":"JR Gibbs","year":"1971","journal-title":"Postgrad Med J"},{"issue":"4","key":"pone.0282726.ref022","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"J Hillman","year":"2002","journal-title":"J Neurosurg"},{"issue":"5","key":"pone.0282726.ref023","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","article-title":"Tranexamic acid in subarachnoid hemorrhage. A double-blind study","volume":"10","author":"M Kaste","year":"1979","journal-title":"Stroke"},{"issue":"6118","key":"pone.0282726.ref024","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","article-title":"Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?","volume":"1","author":"RS Maurice-Williams","year":"1978","journal-title":"Br Med J"},{"issue":"10269","key":"pone.0282726.ref025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.","volume":"397","author":"R Post","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"pone.0282726.ref026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group","volume":"54","author":"Y. Roos","year":"2000","journal-title":"Neurology"},{"issue":"1\u20132","key":"pone.0282726.ref027","first-page":"1","article-title":"Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms.","volume":"102","author":"SA Tsementzis","year":"1990","journal-title":"A double-blind placebo-controlled study. Acta Neurochir (Wien)"},{"issue":"7","key":"pone.0282726.ref028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"M Vermeulen","year":"1984","journal-title":"N Engl J Med"},{"issue":"13","key":"pone.0282726.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16130","article-title":"CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury\u2014a nested randomised, placebo-controlled trial.","volume":"16","author":"P Perel","year":"2012","journal-title":"Health Technol Assess."},{"issue":"10210","key":"pone.0282726.ref030","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.","volume":"394","author":"collaborators C-t","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"pone.0282726.ref031","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1574887114666190620112829","article-title":"Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial.","volume":"14","author":"P Ebrahimi","year":"2019","journal-title":"Rev Recent Clin Trials."},{"key":"pone.0282726.ref032","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of Tranexamic Acid on Prevention of Hemorrhagic Mass Growth in Patients with Traumatic Brain Injury.","volume":"109","author":"E Fakharian","year":"2018","journal-title":"World Neurosurg"},{"issue":"1","key":"pone.0282726.ref033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial","volume":"20","author":"A Jokar","year":"2017","journal-title":"Chin J Traumatol"},{"issue":"1","key":"pone.0282726.ref034","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574887114666191118111826","article-title":"Intravenous Tranexamic Acid for Brain Contusion with Intraparenchymal Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial.","volume":"15","author":"M Mousavinejad","year":"2020","journal-title":"Rev Recent Clin Trials."},{"issue":"10","key":"pone.0282726.ref035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury","volume":"324","author":"SE Rowell","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"pone.0282726.ref036","first-page":"223","article-title":"Effect of Intravenous Tranexamic Acid on Intracerebral Brain Hemorrhage in Traumatic Brain Injury.","volume":"31","author":"H Safari","year":"2021","journal-title":"Turk Neurosurg"},{"key":"pone.0282726.ref037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial.","volume":"13","author":"S Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med."},{"issue":"8","key":"pone.0282726.ref038","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1161\/STROKEAHA.120.032426","article-title":"Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign","volume":"52","author":"C Ovesen","year":"2021","journal-title":"Stroke"},{"issue":"4","key":"pone.0282726.ref039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","article-title":"Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review.","volume":"33","author":"W Hu","year":"2019","journal-title":"CNS Drugs."},{"key":"pone.0282726.ref040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ajem.2021.09.047","article-title":"Tranexamic acid for subarachnoid hemorrhage: A systematic review and meta-analysis.","volume":"50","author":"Y Feng","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"pone.0282726.ref041","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s12630-021-01967-7","article-title":"Tranexamic acid: current use in obstetrics, major orthopedic, and trauma surgery","volume":"68","author":"J Wong","year":"2021","journal-title":"Can J Anaesth"},{"issue":"6","key":"pone.0282726.ref042","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.N.00068","article-title":"Antifibrinolytic Therapy for Perioperative Blood Conservation in Lower-Extremity Primary Total Joint Arthroplasty.","volume":"3","author":"RP Nadeau","year":"2015","journal-title":"JBJS Rev"},{"issue":"10241","key":"pone.0282726.ref043","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.","volume":"395","author":"H-IT Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"pone.0282726.ref044","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery","volume":"376","author":"PS Myles","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"pone.0282726.ref045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery","volume":"384","author":"L Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0282726.ref046","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00266-021-02486-y","article-title":"Efficacy and Safety of Tranexamic Acid for the Control of Surgical Bleeding in Patients Under Liposuction.","volume":"46","author":"FA Rodriguez-Garcia","year":"2022","journal-title":"Aesthetic Plast Surg."},{"key":"pone.0282726.ref047","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3389\/fphar.2019.01079","article-title":"Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage.","volume":"10","author":"Z Shao","year":"2019","journal-title":"Front Pharmacol."},{"issue":"7","key":"pone.0282726.ref048","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.","volume":"9","author":"T Steiner","year":"2014","journal-title":"Int J Stroke."},{"issue":"3","key":"pone.0282726.ref049","doi-asserted-by":"crossref","first-page":"V","DOI":"10.1177\/23969873221099736","article-title":"European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms.","volume":"7","author":"N Etminan","year":"2022","journal-title":"Eur Stroke J."},{"issue":"11","key":"pone.0282726.ref050","doi-asserted-by":"crossref","first-page":"101328","DOI":"10.1016\/j.cpcardiol.2022.101328","article-title":"Essential Topics About the Imaging Diagnosis and Treatment of Hemorrhagic Stroke: A Comprehensive Review of the 2022 AHA Guidelines.","volume":"47","author":"CA Gil-Garcia","year":"2022","journal-title":"Curr Probl Cardiol."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:11:01Z","timestamp":1680286261000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282726"}},"subtitle":[],"editor":[{"given":"Chinh Quoc","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0282726","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}